AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Strategic Challenges | Learn about ATR's navigation of raw material costs, currency fluctuations, and competitive pressures in the evolving packaging industry |
Market Momentum | Discover how ATR's 39.32% YTD return and analyst projections of $5.35-$6.00 EPS for FY24-25 reflect its strong market position |
Financial Fortitude | Delve into ATR's robust balance sheet, with net debt to EBITDA at 1x, enabling strategic investments and consistent dividend increases |
Pharma Powerhouse | Explore AptarGroup's dominance in drug delivery systems, driving growth through innovation in biologics packaging and elastomeric components |
Metrics to compare | ATR | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipATRPeersSector | |
---|---|---|---|---|
P/E Ratio | 28.4x | 14.6x | 2.1x | |
PEG Ratio | 1.64 | 0.22 | 0.00 | |
Price / Book | 4.1x | 1.2x | 1.6x | |
Price / LTM Sales | 3.0x | 1.1x | 1.3x | |
Upside (Analyst Target) | 7.8% | 2.9% | 22.0% | |
Fair Value Upside | Unlock | 8.8% | 2.3% | Unlock |